跳至主要内容
临床试验/ACTRN12620000287932
ACTRN12620000287932已完成1 期

A single dose, randomized, open label, pilot study of a test formulation of (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid capsule in a 2 way crossover comparison against the innovator (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid capsule conducted under fasting conditions in healthy male volunteers.

Zenith Technology Corporation Limited0 个研究点目标入组 24 人开始时间: 2020年3月4日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
Male

入选标准

  • Healthy males volunteers.
  • Aged between 18 and 55
  • Non-smoker
  • BMI between 18 and 30
  • Normal, healthy individuals as determined by medical history, physical examination, ECG, blood pressure and laboratory tests
  • Able to provide written informed consent

排除标准

  • Concomitant drug therapy of any kind
  • Any clinically significant medical conditions
  • Sensitive to the study drug
  • History of any conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
  • Smoker (anyone who has smoked in the last 6 months)
  • History of alcohol or drug abuse or dependency
  • Participation in a drug study within 60 days of the start of the study or donated blood within the 60 days preceding the study
  • Volunteers for whom the Clinical Investigator believer, for any reason, that participation would not be an acceptable risk

研究者

相似试验

已完成
1 期
Comparative assessment of the absorption of a generic formulation of atorvastatin oral spray against the innovator atorvastatin capsule conducted under fasting conditions in healthy male and female volunteersPilot pharmacokinetic study conducted in healthy volunteers comparing two formulations of atorvastatin (oral spray and capsule) with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, atorvastatin is used as an adjunct to diet for the treatment of patients with hypercholesterolaemia.Pilot pharmacokinetic study conducted in healthy volunteers comparing two formulations of atorvastatin (oral spray and capsule) with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, atorvastatin is used as an adjunct to diet for the treatment of patients with hypercholesterolaemia.Blood - Other blood disordersMetabolic and Endocrine - Other metabolic disorders
ACTRN12618000208202Zenith Technology Corp Ltd12
招募中
不适用
A randomized, open-label, and single-dose study to evaluate the safety and the pharmacokinetics after concurrent administration of UIC202007 and UIC202008 in healthy adult subjects
KCT0005901Korea United Pharm30
已完成
1 期
Comparative assessment of the absorption of 3 generic formulations of isotretinoin capsules against the innovator isotretinoin capsule in a pilot study conducted under fasting conditions in healthy male volunteers
ACTRN12615000569505Zenith Technology Corp Ltd16
已完成
1 期
Mass balance study of [14C]-REN001 in healthy male subjectsPrimary mitochondrial myopathy (rare genetic diseases that cause muscles to not function properly)Genetic Diseases
ISRCTN57533271Reneo Pharma Ltd6
尚未招募
1 期
A Single Dose, Randomized, Open-label, One-period Parallel Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product (Arava) in Healthy Thai Male Volunteers under Fasting ConditionsBioequivalence Study Healthy Thai VolunteersLeflunomide 20 mg Film-coated Tablets Bioequivalence Study Healthy Thai Volunteers
TCTR20210215001International Bio Service Co.,Ltd.44